Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $35.89 ($791K) on 2022-01-05, disclosed to the SEC on 2022-01-06.
Open-market sale of $791k HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.89 | 4,255 | $153K | 19.3% |
| 2 | $35.89 | 4,255 | $153K | 19.3% |
| 3 | $37.15 | 4,999 | $186K | 23.5% |
| 4 | $37.15 | 4,999 | $186K | 23.5% |
| 5 | $38.04 | 1,496 | $57K | 7.2% |
| 6 | $38.04 | 1,496 |
| $57K |
| 7.2% |
| Total | $36.78 avg | 21,500 | $791K | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2021-12-29 | $183K | — | Filing → |